» Articles » PMID: 30894578

Inflammatory Disease and C-reactive Protein in Relation to Therapeutic Ionising Radiation Exposure in the US Radiologic Technologists

Overview
Journal Sci Rep
Specialty Science
Date 2019 Mar 22
PMID 30894578
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic inflammation underlies many autoimmune diseases, including hypothyroidism, hyperthyroidism, and rheumatoid arthritis, also type-2 diabetes and osteoarthritis. Associations have been suggested of high-dose ionising radiation exposure with type-2 diabetes and elevated levels of C-reactive protein, a marker of chronic inflammation. In this analysis we used a proportional hazards model to assess effects of radiotherapy on risks of subsequent inflammatory disease morbidity in 110,368 US radiologic technologists followed from a baseline survey (1983-1989/1994-1998) through 2008. We used a linear model to assess log-transformed C-reactive protein concentration following radiotherapy in 1326 technologists. Relative risk of diabetes increased following radiotherapy (p < 0.001), and there was a borderline significant increasing trend per treatment (p = 0.092). For osteoarthritis there was increased relative risk associated with prior radiotherapy on all questionnaires (p = 0.005), and a significant increasing trend per previous treatment (p = 0.024). No consistent increases were observed for other types of inflammatory disease (hypothyroidism, hyperthyroidism, rheumatoid arthritis) associated with radiotherapy. There was a borderline significant (p = 0.059) increasing trend with dose for C-reactive protein with numbers of prior radiotherapy treatments. Our results suggest that radiotherapy is associated with subsequent increased risk of certain inflammatory conditions, which is reinforced by our finding of elevated levels of C-reactive protein.

Citing Articles

Pilot screening of potential matrikines resulting from collagen breakages through ionizing radiation.

Montanari J, Schwob L, Marie-Brasset A, Vinatier C, Lepleux C, Antoine R Radiat Environ Biophys. 2024; 63(3):337-350.

PMID: 39115696 PMC: 11341654. DOI: 10.1007/s00411-024-01086-z.


Low-dose radiation exaggerates HFD-induced metabolic dysfunction by gut microbiota through PA-PYCR1 axis.

Ju Z, Guo P, Xiang J, Lei R, Ren G, Zhou M Commun Biol. 2022; 5(1):945.

PMID: 36088469 PMC: 9464247. DOI: 10.1038/s42003-022-03929-1.


RNA-seq based integrative analysis of potential crucial genes and pathways associated with patellar instability.

Xu C, Dong Z, Ji G, Yan L, Wang X, Li K Bioengineered. 2022; 13(5):11402-11416.

PMID: 35510414 PMC: 9275973. DOI: 10.1080/21655979.2022.2062528.

References
1.
Sigurdson A, Doody M, Rao R, Freedman D, Alexander B, Hauptmann M . Cancer incidence in the US radiologic technologists health study, 1983-1998. Cancer. 2003; 97(12):3080-9. DOI: 10.1002/cncr.11444. View

2.
van Nimwegen F, Schaapveld M, Janus C, Krol A, Raemaekers J, Kremer L . Risk of diabetes mellitus in long-term survivors of Hodgkin lymphoma. J Clin Oncol. 2014; 32(29):3257-63. DOI: 10.1200/JCO.2013.54.4379. View

3.
Cengiz M, Akbulut S, Atahan I, Grigsby P . Acute phase response during radiotherapy. Int J Radiat Oncol Biol Phys. 2001; 49(4):1093-6. DOI: 10.1016/s0360-3016(00)01426-7. View

4.
Simon S, Preston D, Linet M, Miller J, Sigurdson A, Alexander B . Radiation organ doses received in a nationwide cohort of U.S. radiologic technologists: methods and findings. Radiat Res. 2014; 182(5):507-28. PMC: 4406479. DOI: 10.1667/RR13542.1. View

5.
Kemp A, Preen D, Saunders C, Holman C, Bulsara M, Rogers K . Ascertaining invasive breast cancer cases; the validity of administrative and self-reported data sources in Australia. BMC Med Res Methodol. 2013; 13:17. PMC: 3599953. DOI: 10.1186/1471-2288-13-17. View